[Clinico-statistical study on the anti-inflammatory activity of proglumetacin. Proglumetacin: at last a complete anti-inflammatory agent?].
Fifty outpatients suffering from rheumatoid disorders were treated with proglumetacin. Efficacy was classified as "good" or "very good" in 80% of cases. Besides this considerable efficacy, a tolerance classified as "good" or "very good" was observed in 86% of patients.
D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006073:Gout / Q000188:drug therapy; D006801:Humans; D007210:Indoleacetic Acids / Q000627:therapeutic use*; D007405:Intervertebral Disc Displacement / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy*; D010489:Periarthritis / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000188:drug therapy*
D007210:Indoleacetic Acids; C019541:proglumetacin
Studio clinico-statistico sull'attività antiinfiammatoria della proglumetacina. La proglumetacina: finalmente un antiinfiammatorio completo?